These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8674257)

  • 1. Stress-induced hemodynamic and hemostatic changes in patients with systemic hypertension: effect of verapamil.
    Gebara OC; Jimenez AH; McKenna C; Mittleman MA; Xu P; Lipinska I; Muller JE; Tofler GH
    Clin Cardiol; 1996 Mar; 19(3):205-11. PubMed ID: 8674257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrasting effects of verapamil and amlodipine on cardiovascular stress responses in hypertension.
    Lefrandt JD; Heitmann J; Sevre K; Castellano M; Hausberg M; Fallon M; Urbigkeit A; Rostrup M; Agabiti-Rosei E; Rahn KH; Murphy M; Zannad F; de Kam PJ; Smit AJ
    Br J Clin Pharmacol; 2001 Dec; 52(6):687-92. PubMed ID: 11736880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of nadolol on hemodynamic and hemostatic responses to potential mental and physical triggers of myocardial infarction in subjects with mild systemic hypertension.
    Jimenez AH; Tofler GH; Chen X; Stubbs ME; Solomon HS; Muller JE
    Am J Cardiol; 1993 Jul; 72(1):47-52. PubMed ID: 8517427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative trial of controlled-onset, extended-release verapamil, enalapril, and losartan on blood pressure and heart rate changes.
    Bakris G; Sica D; Ram V; Fagan T; Vaitkus PT; Anders RJ
    Am J Hypertens; 2002 Jan; 15(1 Pt 1):53-7. PubMed ID: 11824861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sustained-release Verapamil on the morning systemic arterial pressure surge during daily activity in patients with systemic hypertension.
    Rosito GA; Gebara OC; McKenna CA; Solomon HS; Muller JE; Tofler GH
    Am J Cardiol; 1997 May; 79(9):1252-5. PubMed ID: 9164897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive treatment with verapamil and amlodipine. Their effect on the functional autonomic and cardiovascular stress responses.
    Nazzaro P; Manzari M; Merlo M; Triggiani R; Scarano AM; Lasciarrea A; Pirrelli A
    Eur Heart J; 1995 Sep; 16(9):1277-84. PubMed ID: 8582392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension.
    Ding YA; Chou TC; Lin KC
    J Hum Hypertens; 1994 Apr; 8(4):273-8. PubMed ID: 8021907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circadian heart rate response to chronotherapy versus conventional therapy in patients with hypertension and myocardial ischemia.
    Glasser SP; Frishman W; White WB; Stone P; Johnson MF
    Clin Cardiol; 2000 Jul; 23(7):524-9. PubMed ID: 10894441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender and age effects on the ambulatory blood pressure and heart rate responses to antihypertensive therapy.
    White WB; Johnson MF; Black HR; Elliott WJ; Sica DA
    Am J Hypertens; 2001 Dec; 14(12):1239-47. PubMed ID: 11775133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of amlodipine, verapamil and placebo in the treatment of mild to moderate hypertension. Amlodipine Study Group.
    Lorimer AR; Smedsrud T; Walker P; Tyler HM
    J Hum Hypertens; 1989 Jun; 3(3):191-6. PubMed ID: 2527993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of verapamil on home self-measurement of blood pressure and heart rate by hypertensive patients. Verapamil-Frequency Research Group.
    Fernández-González R; Gómez-Pajuelo C; Gabriel R; de La Figuera M; Moreno E; of The Verapamil-Frequency Res
    Blood Press Monit; 2000 Feb; 5(1):23-30. PubMed ID: 10804447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of verapamil on cardio- and hemodynamics in rats with various models of hypertension].
    Spasov AA; Gurbanov KG; Seredintseva NV; Paperno AA
    Eksp Klin Farmakol; 1997; 60(3):30-3. PubMed ID: 9324394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Less adrenergic response to mental task during verapamil compared to amlodipine treatment in hypertensive subjects.
    Sevre K; Lefrandt JD; Eide I; Smit AJ; Rostrup M
    Blood Press; 2001; 10(2):111-5. PubMed ID: 11467760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fixed combination trandolapril/verapamil sustained-release: a review of its use in essential hypertension.
    Muijsers RB; Curran MP; Perry CM
    Drugs; 2002; 62(17):2539-67. PubMed ID: 12421112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.
    Black HR; Elliott WJ; Grandits G; Grambsch P; Lucente T; White WB; Neaton JD; Grimm RH; Hansson L; Lacourciere Y; Muller J; Sleight P; Weber MA; Williams G; Wittes J; Zanchetti A; Anders RJ;
    JAMA; 2003 Apr 23-30; 289(16):2073-82. PubMed ID: 12709465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sustained-release verapamil therapy on the blood pressure at rest and on the pressor response to isometric exertion in hypertensive patients.
    Cardillo C; Musumeci V; Savi L; Guardigli R; Mores N; Folli G
    Eur J Clin Pharmacol; 1988; 34(6):549-53. PubMed ID: 3169108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium antagonists and beta blockers in the control of mild to moderate systemic hypertension, with particular reference to verapamil and propranolol.
    Singh BN; Rebanal P; Piontek M; Nademanee K
    Am J Cardiol; 1986 Feb; 57(7):99D-105D. PubMed ID: 2869676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the antihypertensive efficacy and safety of using sustained release verapamil in elderly subjects using ambulatory blood pressure monitoring].
    Jasiński T; Janicki K; Klima M; Pieniazek W; Bednarz S
    Przegl Lek; 1996; 53(2):73-7. PubMed ID: 8754325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined terazosin and verapamil therapy in essential hypertension. Hemodynamic and pharmacokinetic interactions.
    Lenz ML; Pool JL; Laddu AR; Varghese A; Johnston W; Taylor AA
    Am J Hypertens; 1995 Feb; 8(2):133-45. PubMed ID: 7755941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronotherapeutic delivery of verapamil in obese versus non-obese patients with essential hypertension.
    White WB; Elliott WJ; Johnson MF; Black HR
    J Hum Hypertens; 2001 Feb; 15(2):135-41. PubMed ID: 11317194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.